<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1618">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02080000</url>
  </required_header>
  <id_info>
    <org_study_id>ROC001</org_study_id>
    <nct_id>NCT02080000</nct_id>
  </id_info>
  <brief_title>R-wave Optimisation in Cardiac Resynchronisation Therapy Study</brief_title>
  <official_title>Use of the R-wave to Optimise VV Delay in Heart Failure Patients Treated With Cardiac Resynchronisation Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Royal Bournemouth Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Royal Bournemouth Hospital</source>
  <oversight_info>
    <authority>United Kingdom: National Health Service, Research and Development Department</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate whether the use of a simple feature on the 12 lead
      electrocardiogram (ECG) to optimise pacemaker device programming can have clinically
      relevant benefit to patient management. More specifically it is to investigate whether using
      the R-wave in V1 of the surface ECG to guide the timings between left (LV) and right
      ventricular (RV) pacing improves response to Cardiac Resynchronisation Therapy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Quality of Life Score</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>6 minute hall walk distance</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left Ventricular End Systolic Volume Index</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Hospitalisation for any cause</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Hospitalisation for Heart Failure</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Heart Failure, Systolic</condition>
  <arm_group>
    <arm_group_label>Optimised V-V timing delay</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>V-V timing delay setting on biventricular pacemaker will be optimised guided by size of R-wave on surface ECG</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard V-V timing delay</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Optimisation of V-V timing using R wave on surface ECG</intervention_name>
    <arm_group_label>Optimised V-V timing delay</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard V-V timing settings</intervention_name>
    <arm_group_label>Standard V-V timing delay</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  The patient must have a biventricular pacemaker in situ, implanted for NYHA Class III
             / IV heart failure syndrome with impaired systolic function.

          -  Implantation indication must have included a left ventricular ejection fraction
             measured on transthoracic echo of &lt;35% and either

               -  a QRS duration of &gt;150ms or

               -  a QRS duration of 120 - 149ms with further evidence of dyssynchrony confirmed by
                  echocardiography.

          -  Participants must have &gt;95% true biventricular pacing over the 1 month before
             enrolment and throughout the observation period.

          -  The biventricular paced QRS complex morphology in lead V1 of subject's standard 12
             lead surface ECG must show an R wave height of &lt; 1mm or &lt;20% of the total QRS
             deflection with standard LV offset settings applied.

          -  The subject's standard 12 lead surface ECG must show a right bundle branch block
             pattern in lead V1 during LV only pacing.

          -  The participant must be willing to comply with the protocol requirements including
             travelling to the Royal Bournemouth Hospital for the attendances required for the
             study and intend to have their long term device follow up at the Royal Bournemouth
             Hospital at the time of enrolment.

          -  Provision of informed consent Exclusion criteria

          -  Hypertrophic or restrictive cardiomyopathy

          -  Suspected acute myocarditis

          -  Correctable Valvulopathy

          -  An Acute Coronary Syndrome within the last 3 months

          -  Recent (within the last 3 months) or scheduled coronary revascularisation

          -  Treatment resistant hypertension

          -  Severe obstructive lung disease

          -  Pregnancy at the time of enrolment or a desire to become pregnant during the study
             period

          -  An inability to walk

          -  Reduced life expectancy not associated with cardiovascular disease (less than 1 year)

          -  Unable to provide informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>John R Paisey, MD</last_name>
    <phone>01202303626</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Robert W Bowers, MBBS</last_name>
    <phone>01202 303626</phone>
    <phone_ext>5820</phone_ext>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Royal Bournemouth Hospital</name>
      <address>
        <city>Bournemouth</city>
        <state>Dorset</state>
        <zip>BH7 7DW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert W Bowers, MBBS</last_name>
      <phone>01202 303626</phone>
      <phone_ext>5820</phone_ext>
    </contact>
    <investigator>
      <last_name>Robert W Bowers, MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>John R Paisey, DM</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 4, 2014</lastchanged_date>
  <firstreceived_date>March 4, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart Failure</keyword>
  <keyword>Cardiac Resynchronisation Therapy</keyword>
  <keyword>Biventricular Pacemaker</keyword>
  <keyword>Optimisation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Heart Failure, Systolic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
